Grown Rogue International (GRUSF) Exchange Rate Effect (2009 - 2025)
Grown Rogue International's (GRUSF) quarterly Exchange Rate Effect came in at -$4.0 billion in Q4 2025, down 59415294.82% year-on-year from N/an in Q4 2024, and down 73695062.97% quarter-over-quarter from $5460.3 in Q1 2025.
Grown Rogue International (GRUSF) Exchange Rate Effect (2009 - 2025) Analysis & Trends
Grown Rogue International's Exchange Rate Effect history runs 14 years deep, the most recent figure standing at -$4.0 billion for Q4 2025.
- On a quarterly basis, Exchange Rate Effect fell 59415294.82% year-over-year to -$4.0 billion in Q4 2025; TTM through Dec 2025 was -$4.0 billion, a 31084512.24% decrease from a year earlier, with the FY2025 full-year figure at $4024.0, up 130.85% from the prior year.
- Exchange Rate Effect slipped to -$4.0 billion in Q4 2025 per GRUSF's latest filing, from $5460.3 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $2.8 billion in Q4 2021 and bottomed at -$4.0 billion in Q4 2025.
- The 5-year median for Exchange Rate Effect is -$387.05 (2024), against an average of -$81.0 million.
- Across the five-year window, Exchange Rate Effect surged 11719965.73% in 2021 and sank 59415294.82% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $2.8 billion in 2021, then slumped by 100.0% to $1427.7 in 2022, then slumped by 262.36% to -$2317.9 in 2023, then plunged by 192.18% to -$6772.6 in 2024, then slumped by 59415294.82% to -$4.0 billion in 2025.
- Per Business Quant, the three latest GRUSF Exchange Rate Effect figures stand at -$4.0 billion (Q4 2025), $5460.3 (Q1 2025), and -$6772.6 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.02 Bn |
| Dec 31, 2025 | -4.02 Bn |
| Mar 31, 2025 | 5,460.34 |
| Mar 31, 2025 | 5,460.34 |
| Dec 31, 2024 | -6,772.65 |
| Dec 31, 2024 | -6,772.65 |
| Sep 30, 2024 | -387.05 |
| Sep 30, 2024 | -387.05 |
| Jun 30, 2024 | -3,752.21 |
| Jun 30, 2024 | -3,752.21 |
| Mar 31, 2024 | -2,033.39 |
| Mar 31, 2024 | -2,033.39 |
| Oct 31, 2023 | -2,317.94 |
| Oct 31, 2023 | -2,317.94 |
| Jul 31, 2023 | 2,337.00 |
| Jul 31, 2023 | 2,337.00 |
| Apr 30, 2023 | -1,891.00 |
| Apr 30, 2023 | -1,891.00 |
| Jan 31, 2023 | 691.72 |
| Jan 31, 2023 | 691.72 |